, S. 2un (Spon. by R. Rapkin) Sch, Children's Hosp. of NJ, Neonatology, Newark,NJ To study the relationship between intravascular arterial PP and the development of symptomatic PDA in VLBW infants (BW (1500 gm), 13 preterm neonates (m GA 27.5 wks range 25-31 wks, m BW 975 gms range 560-1360) were systematically and continuously monitored in terms of, (1) the onset of diuresis, (2) changes in Fi02, (3) x-ray evidence of increased pulmonary flow, (4) continuous arterial PP (determined via UA or radial line), (5) pulse pressure/systolic BP ratio (PP/SBP), (6) daily LA/AO ratio and (7) characteristic PDA murmur. Seven patients developed symptomatic PDA which is defined as the combination of aforementioned items 3,7, and LA/AO ratio of >1.2. Retrospective analysis of PP (mmHg) in 7 symptomatic (sym) and 6 asymptomatic (asym) infants revealed the following:
To observe the timing and sequence of appearance of presenting signs of symptomatic PDA, we continuously and systematically monitored, (1) the onset of diuresis (through intake and output calculation), (2) changes in Fi02 , (3)
x-ray evidence of increased pulmonary flow, (4) pulse pressure (determined through UA or radial line),
pulse pressure/systolic pressure ratio (PP/SBP), (6) daily LA/AO ratio and (7) the first appearance of PDA murmur in 7 VLBW (<1500 gm) infants from birth until most PDA symptoms fully developed. The chain of events began with the onset of diuresis on an average of the 4th day (range 2-8 day) with an abrupt increase in mean urine output of 450% (range 231-775%) compared to the previous day. The Fi02 requirement invariably dropped below 30% one day after the onset of diuresis (i.e. av. 5th day). 12 to 24 hrs later (6th day) the evidence of increased pulmonary flow presented itself on x-rays, this was the time when PP began to widen. By the 7th day of life PP reached 20 mmHg or above and PP/SP ratio exceeded 48% (range 43-55%). Clinical evidence of bounding pulses was obvious at this time. By the 8th day (range 6-11th day) LA/AO ratio had reached >1.2 and on an average of the 9th day (range 7-10th day) the typical PDA murmur finally appeared. Although the timing of appearance may differ in each case, the sequence of events remained the same. Understanding the order of these events helps manage PDA better.
LONG TERM MANAGEMENT PROBLEMS IN CARNITINE
Department of Pediatrics, University of Chicago and Department of Neurology, University of Wisconsin, Madison, Wisconsin.
Systemic carnitine deficiency (SCD) can cause congestive cardiomyopathy (CCM) and dysrhythmia, with or without myopathy, hypoglycemia, and encephalopathy. In many cases, SCD is due to renal tubular loss (RTL) of carnitine esters. We studied 2 patients with SCD and CCM, treated for 4 and 21 years with L-carnitine (C). Pre-Rx studies included: plasma C, 4.8 and 8.4 mcM ; muscle C, 30.0 and 82.1 nmol/gm (NL 2500-5000); LV ejection fraction (EF), 45% and 32%. Patient 1 had syncope with sinus node dysfunction; patient 2 had bradycardia with fasting. After 1 year of C at 50-75 mg/kg/d, muscle C was 1273 and 3103 nmol/gm, EF was 65% and 61%. LV wall and septa1 thickness were > 3 S.D. above mean. 24 hour fasts did not cause hypoglycemia or dysrhythmia, but mild ketonemia occurred. When C was withheld, RTL persisted and plasma C fell within 12 hours (12.7 and 23.3 mcM). Urine C remained high (663 mcM/L (NL 330 + 30) despite low plasma C. In both patients, symptoms recur episodically. Patient 1 had worsening LVH with strain, bradycardia, and syncope after a pubertal growth spurt (plasma C 19.8 mcM We examined cardiac catheterization (cath) data of 104 children with VSD and left to right shunt, with 1st cath in the 1st year and a later cath without intervening surgery. 19% had pulmonic stenosis (PS) initially. Of the remaining 84, 20% later developed PS, leaving 67. 12% of the 67 VSD's were small, with right ventricular systolic pressure/left ventricular systolic pressure (RVSP/LVSP)I .39, 27% were 4 systemic (RVSP/LVSP .40-.60), 29% were 2/3 systemic (RVSP/LVSP .61-.74) and 32% were nonrestrictive (NR) (RVSP/LVSP .75-1.0). For the 67 without PS, pulmonary artery (PA) systolic pressure fell or was unchanged on later cath in LOO%, 89%, 83%, & 57% of the small, 4 systemic,2/3 systemic and NR groups respectively. Mean PA pressure fell or was unchanged in loo%, 89%, 80%, & 39% respectively. RVSP/LVSP fell more than .10 in 50%, 78%, 83%, & 52% respectively. Thus the defect got smaller in 40/67 for all groups. Pulmonary vascular resistance (PVR) increased in 7/67, and these 7 were all in the 2/3 systemic or NR groups.
41 of the 104 patients had 2 caths in the first year. 28/41 never had PS, and of these 28, 14 were NR and 10 were 2/3 systemic. Of the 14 NR, 7 got smaller and 3 of the other 7 increased PVR. Of the 10 in the 2/3 systemic group, 8 became smaller and 2 increased PVR.
We conclude that for patients with 2/3 systemic or NR VSD's, it is much more common for the defect to get smaller than for the PVR to increase. in patlents wlth dl lated cardlomyopathies, plasma C has been reported to be both below and above the normal range. Others have postulated that elevated plasma C reflects increased C synthesls. Renal excretion is the only route for C loss. We hypothesized that elevated plasma C might be related to Impaired renal functlon. We measured plasma C and creatinlne clearance In 15 patients wlth dl lated cardlomyopathy, aged 19 to 64 yrs. Plasma C and creatlnlne clearance were negatlvel y correlated (Fla, r=-.59. ~<.02). In one of the ~atlents, a -.
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. . volume infusion for all 3 stages. Although there is considerable change in embryo and ventricular weight, heart geometric shape, and myofibril myocyte volume and a1 ignment, the relationship between preload and stroke volume is similar at each stage. We conclude that the Frank-Starling mechanism functions over a broad range of development in the preinnervated embryonic heart.
